Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI
Prostate Cancer: New ESTRO Recommendations for Precision Radiotherapy
Monica Bertagnolli: Don't Abolish the NIH, Fix It
Felicia Marie Knaul: WHO to Present First Global Estimates of 5-Year Breast Cancer Survival
ESTRO Sets Practical Guidance for Focal Boosting in Prostate Cancer Radiotherapy 2026
Daraxonrasib for Pancreatic Cancer: What’s Next?
BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases
Can SABR Replace Surgery in Selected Low-Risk Breast Cancer?
The 2026 NCODA International Fall Summit is a premier educational event for the global oncology community, scheduled for October 28–30, 2026, in Orlando, Florida. The summit is designed to foster […]
